Precision Medicine available to all. Our mission is to deliver top tier ArtificiaI Intelligence to accelerate the search and development of biomarkers, medicines and therapies to significantly improves people’s lives. We exist to create healthcare solutions were passion and purpose come together.
All action is an opportunity. To learn. To change…
At Cellter we are currently using our AI-platform Node (A.K.A Panchito) to generate our own pipeline of therapeutic molecules for the following Therapeutic areas.
Stem cell mobilization
At Cellter we seek to collaborate with leading global pharmaceutical companies with a proven track record in clinical experience, for completion of the final phases of the clinical trials, and commercial capabilities, to successfully bring our innovative developments to market. We believe that this is the way to combine our drug discovery cutting-edge technologies with your commercial development capabilities.
Join us to create the health of future, now.
Working at Cellter
Setting Higher Standards. It takes a strong sense of passion and purpose to do something that has never been done before. We are a diverse team of innovative scientists, clinicians, and business leaders with a common goal of building a great company. It is a rare opportunity to join a highly engaged team where everyone has the opportunity to contribute to bringing innovative diagnostics, medicines and therapies that make health available to all. Come talk with us; we want to hear from you.
CHECK OUT OUR SPECIAL ON COVID-19
In December 2019, several patients from Wuhan, China, entered with symptoms of pneumonia. As the number of patients with similar symptoms began to increase, the causative agent was finally isolated from the samples. It was initially named the new 2019 coronavirus (2019-nCoV) and has recently been re-labeled as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); The disease it causes has been called coronavirus disease 2019 (COVID-19).
Over the next few weeks, the virus spread from Wuhan to affect different provinces in China and, after a few months, it is now present in 169 countries. As of March 24, 2020, there have been 415,876 confirmed cases worldwide, 18,574 deaths have been recorded and 107,811 patients have recovered.